Takeda – Recall of Natpara® (parathyroid hormone)
September 5, 2019 - Takeda announced a voluntary patient-level recall of all doses of Natpara (parathyroid hormone) injection due to a potential issue related to rubber particulates originating from the rubber septum of the Natpara cartridge.
Download PDF
